We are live on ! Find out more
GBA

Garrison Bradford & Associates Portfolio holdings

AUM $92.2M
1-Year Est. Return 19.08%
This Fund
S&P 500
This Quarter Est. Return
+10.3%
1 Year Est. Return
+19.08%
3 Year Est. Return
+63.45%
5 Year Est. Return
+93.47%
10 Year Est. Return
+398.58%
AUM
$90.7M
AUM Growth
+$5.93M
Cap. Flow
-$2.06M
Cap. Flow %
-2.27%
Top 10 Hldgs %
78.73%
Holding
32
New
1
Increased
7
Reduced
11
Closed
1

Top Buys

Rank Stock Value
1
LNG icon
Cheniere Energy
LNG
+$345K
2
PWR icon
Quanta Services
PWR
+$296K
3
ROP icon
Roper Technologies
ROP
+$206K
4
MSFT icon
Microsoft
MSFT
+$160K
5
COST icon
Costco
COST
+$59.3K

Sector Composition

Rank Sector Weight
1 Healthcare 36.81%
2 Industrials 14.14%
3 Financials 13.77%
4 Technology 11.45%
5 Consumer Staples 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
26
Apple
AAPL
$4.57T
$325K 0.36%
1,688
ENB icon
27
Enbridge
ENB
$112B
$278K 0.31%
7,720
ROP icon
28
Roper Technologies
ROP
$39.8B
$218K 0.24%
+400
New +$206K
JNJ icon
29
Johnson & Johnson
JNJ
$625B
$211K 0.23%
1,345
PGF icon
30
Invesco Financial Preferred ETF
PGF
$674M
$160K 0.18%
11,000
SRTS icon
31
Sensus Healthcare
SRTS
$50.5M
$45K 0.05%
18,900
XBI icon
32
State Street SPDR S&P Biotech ETF
XBI
$10.3B
-2,955
Closed -$216K

Similar funds

Garrison Bradford & Associates's Q4 2023 Portfolio in Review

As of Q4 2023, Garrison Bradford & Associates held 32 positions worth $90.7M, up 7% from $84.7M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Garrison Bradford & Associates's Q4 2023 filing shows 1 new, 7 increased, 11 reduced and 1 closed positions. Its largest new stake was Roper Technologies: 400 shares worth $218K. The largest sale was UnitedHealth, an estimated $1.08M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 39% a quarter earlier, followed by Industrials and Financials.

  • Garrison Bradford & Associates's largest Q4 2023 buy was Roper Technologies: 400 shares worth $218K.
  • Garrison Bradford & Associates added most to Cheniere Energy in Q4 2023, an estimated $345K increase.
  • Garrison Bradford & Associates's biggest Q4 2023 reduction was UnitedHealth, cutting an estimated $1.08M.
  • Garrison Bradford & Associates fully exited State Street SPDR S&P Biotech ETF in Q4 2023, selling an estimated $216K.
  • Garrison Bradford & Associates's ten largest holdings make up 79% of its $90.7M portfolio in Q4 2023.
  • Garrison Bradford & Associates opened 1 new position and closed 1 in Q4 2023.
  • Garrison Bradford & Associates's portfolio value rose 7% quarter-over-quarter to $90.7M.

Based on Garrison Bradford & Associates's 13F filing for Q4 2023, filed 25 Jan 2024.